Mixed outlook for chemical financing (ICIS Chemical Business August 27, 2021)Devin Maraj2021-08-30T15:23:56+00:00August 27th, 2021|Featured, Our Publications|
Chemical M&A market in transition (ICIS Chemical Business August 20, 2021)Devin Maraj2021-08-30T15:00:20+00:00August 20th, 2021|Featured, Our Publications|
Pharm Exec: Pharma and Biotech’s 2020 Full-Year View (Young & Partners article – March 2021)news2021-05-28T16:06:59+00:00March 18th, 2021|Featured, Our Publications|
Chemical Industry Financings in 2020 and Outlook (ICIS Chemical Business February 26, 2021)news2021-05-28T16:06:43+00:00March 1st, 2021|Featured, Our Publications|
Chemical M&A – Yearend Summary and Forecast (ICIS Chemical Business, Feb 12, 2021 issue)news2021-05-28T16:07:03+00:00February 26th, 2021|Featured, Our Publications|
Press Release: Société de Chimie Industrielle Elects Peter Young as President (December 10, 2020)news2021-07-01T19:04:05+00:00December 10th, 2020|Our Publications|
Pharma Exec – Taking Pharma’s Pulse in a Tough 2020 (Young & Partners article Sept 2020)news2021-07-01T19:04:52+00:00September 10th, 2020|Our Publications|
Debt and Equity Markets Buoyant (ICIS Chemical Business September 4 2020)news2021-12-03T20:09:58+00:00September 4th, 2020|Our Publications|
Chemical M&A Activity Narrows (Young & Partners Article in ICIS Chemical Business August 28, 2020 issue)news2021-07-01T19:05:29+00:00August 28th, 2020|Our Publications|
Chemical M&A and Financing Healthy, but Coronavirus Clouds the Outlook (ICIS Chemical Business Feb 14-20, 2020)news2021-07-01T19:05:36+00:00February 14th, 2020|Our Publications|
